General Electric Company CEDEAR logo

General Electric Company CEDEAR (GE)

Market Closed
21 Aug, 20:00
BCBA BCBA
AR$
69,525. 00
+1,275
+1.8681%
AR$
- Market Cap
6.6 P/E Ratio
6.89% Div Yield
15,568 Volume
0 Eps
AR$ 68,250
Previous Close
Add Transaction
Day Range
68,750 69,850
Year Range
44,250 76,975
Want to track GE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GE closed yesterday higher at AR$69,525, an increase of 1.8681% from Thursday's close, completing a monthly decrease of -5.0853% or -AR$3,725. Over the past 12 months, GE stock gained 16.7506%.
GE is not paying dividends to its shareholders.
General Electric Company CEDEAR has completed 1 stock splits, with the recent split occurring on Aug 02, 2021.
The company's stock is traded on one exchange.

GE Chart

General Electric Company CEDEAR (GE) FAQ

What is the stock price today?

The current price is AR$69,525.00.

On which exchange is it traded?

General Electric Company CEDEAR is listed on BCBA.

What is its stock symbol?

The ticker symbol is GE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 6.89%.

What is its market cap?

As of today, no market cap data is available.

Has General Electric Company CEDEAR ever had a stock split?

General Electric Company CEDEAR had 1 splits and the recent split was on Aug 02, 2021.

General Electric Company CEDEAR Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Wanyong Lian CEO
BCBA Exchange
369604103 CUSIP
CN Country
94,910 Employees
20 Dec 2019 Last Dividend
2 Aug 2021 Last Split
- IPO Date

Overview

Sinopharm Group Co. Ltd., with its pivotal role outlined within the healthcare sector of the People's Republic of China, operates through its widespread network focusing on the wholesale and retail aspects of pharmaceuticals, medical devices, and various healthcare products. Founded in 2003 and positioned strategically in Shanghai, Sinopharm, through its diversified business model, caters to a comprehensive range of healthcare needs across the nation. It is divided operationally into four primary segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business, ensuring a broad coverage across different healthcare requirements. Beyond the national boundaries, Sinopharm has also established its mark by offering international pharmaceutical and healthcare product manufacturers a host of value-added services including distribution, logistics, and market access services. Notably, Sinopharm Group Co. Ltd. functions under the corporate umbrella of Sinopharm Industrial Investment Co., Ltd., strengthening its corporate synergy and reinforcing its commitment to advancing healthcare access and innovation.

Products and Services

The extensive portfolio of products and services offered by Sinopharm Group Co. Ltd. encapsulates the essence of a comprehensive healthcare provider, attending to a wide spectrum of consumer and business needs within the healthcare industry.

    Pharmaceutical Distribution: Serving as a cornerstone of Sinopharm's offerings, this segment ensures a seamless supply of pharmaceutical products to key stakeholders in the healthcare chain including hospitals, retail pharmacies, clinics, and other distribution channels. Accompanying the distribution are logistics and value-added services catering to both domestic and international markets, aimed at enhancing the efficiency and reach of healthcare solutions.

    Medical Devices: Acknowledging the critical role of technology in modern healthcare, Sinopharm distributes a vast array of medical devices. This initiative bridges the gap between innovative medical technologies and healthcare institutions, thereby facilitating cutting-edge treatments and diagnostics.

    Retail Pharmacy: Through its extensive networks of retail drug stores, which are both owned and franchised, Sinopharm makes healthcare products easily accessible to the general public. This network is a vital component in ensuring community health and wellness by offering a diverse range of pharmaceuticals and related products.

    Other Business Segment: This diverse category includes the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies, further underpining the comprehensiveness of Sinopharm's offerings. Additionally, the group is involved in property management, distribution of Chinese herbal medicines, antibiotics, biological products, and a suite of professional services ranging from IT development, medicine consultation to market research, and project investment management. This amalgamation of services accentuates Sinopharm's integrated approach towards healthcare.

Contact Information

Address: Sinopharm Group Building
Phone: 86 21 2305 2666